|
Q4 2020
Filed on Feb 12, 2021
|
100,000
|
$9.16 - $11.41
$916K - $1.14M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
50,000
|
$33.26 - $59.72
$1.66M - $2.99M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
50,000
|
$22.87 - $32.1
$1.14M - $1.61M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
50,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
25,000
|
$20.81 - $30.55
$520K - $764K
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
155,592
|
$142.35 - $184.32
$22.1M - $28.7M
|
|
Arclight Clean Transition CO
|
Q4 2020
Filed on Feb 12, 2021
|
75,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
280,837
|
$17.0 - $32.36
$4.77M - $9.09M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
53,963
|
$11.06 - $14.01
$597K - $756K
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
87,465
|
$9.44 - $13.3
$826K - $1.16M
|
|
Checkmate Pharmaceuticals In
|
Q4 2020
Filed on Feb 12, 2021
|
44,966
|
N/A
|
|
Climate Change Crisis Real I
|
Q4 2020
Filed on Feb 12, 2021
|
50,000
|
N/A
|
|
Dmy Technology Group Inc Ii
|
Q4 2020
Filed on Feb 12, 2021
|
150,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
132,823
|
$38.9 - $47.18
$5.17M - $6.27M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
579,379
|
$1.61 - $2.85
$933K - $1.65M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
11,200
|
$16.52 - $21.49
$185K - $241K
|
|
Foley Trasimene Acquisition
|
Q4 2020
Filed on Feb 12, 2021
|
3,000,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
379,987
|
N/A
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
50,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
18,166
|
$14.94 - $18.3
$271K - $332K
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
400,000
|
$10.05 - $15.01
$4.02M - $6M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
23,527
|
$35.93 - $51.76
$845K - $1.22M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
6,000
|
$31.74 - $51.34
$190K - $308K
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
95,660
|
N/A
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
1,250,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
31,052
|
$7.97 - $21.66
$247K - $673K
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
283,052
|
$93.77 - $115.29
$26.5M - $32.6M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
743,932
|
$7.86 - $16.94
$5.85M - $12.6M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
198,494
|
$23.34 - $32.22
$4.63M - $6.4M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
14,971
|
$63.26 - $91.14
$947K - $1.36M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
70,000
|
$46.9 - $134.45
$3.28M - $9.41M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
34,499
|
$32.65 - $39.91
$1.13M - $1.38M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
127,534
|
$19.84 - $35.32
$2.53M - $4.5M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
15,299
|
$66.66 - $111.74
$1.02M - $1.71M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
238,877
|
$32.59 - $36.88
$7.79M - $8.81M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
30,000
|
$17.28 - $19.51
$518K - $585K
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
906,813
|
$4.07 - $7.18
$3.69M - $6.51M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
40,000
|
$22.85 - $48.44
$914K - $1.94M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
4,000,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
125,000
|
N/A
|
|
Pieris Pharmaceuticals Inc
|
Q4 2020
Filed on Feb 12, 2021
|
60,333
|
N/A
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
25,000
|
$8.29 - $11.7
$207K - $293K
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
17,200
|
N/A
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
200,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
504,100
|
$15.58 - $20.84
$7.85M - $10.5M
|
|
Reinvent Technology Partners
|
Q4 2020
Filed on Feb 12, 2021
|
100,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
977,769
|
$21.58 - $27.9
$21.1M - $27.3M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
80,614
|
$23.5 - $52.65
$1.89M - $4.24M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
962,546
|
$18.23 - $23.58
$17.5M - $22.7M
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
18,378
|
$62.55 - $74.0
$1.15M - $1.36M
|
|